Personal information

No personal information available

Activities

Collapse all

Employment (1)

Beth Israel Deaconess Medical Center: Boston, MA, US

1994 to present | Director of clinical lymphoma program (Hematology)
Employment
Source: Self-asserted source
Robin Joyce

Education and qualifications (2)

Harvard University: Cambridge, MA, US

MMS
Education
Source: Self-asserted source
Robin Joyce

University of Massachusetts: Worcester, MA, US

1991 to present | MD
Education
Source: Self-asserted source
Robin Joyce

Works (21)

Phase II clinical trial evaluating Abatacept in patients with steroid-refractory chronic graft versus host disease

Blood
2023-03-02 | Journal article
DOI: 10.1182/blood.2022019107
Contributors: Anita G. Koshy; Haesook T. Kim; Jessica Liegel; Jon E. Arnason; Vincent T. Ho; Joseph H. Antin; Robin Joyce; Corey S. Cutler; Mahasweta Gooptu; Sarah Nikiforow et al.
Source: check_circle
Crossref

Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial

Blood Advances
2020-05-26 | Journal article
DOI: 10.1182/bloodadvances.2020001804
Contributors: Jeffrey I. Zwicker; Joanna Roopkumar; Maneka Puligandla; Benjamin L. Schlechter; Anish V. Sharda; David Peereboom; Robin Joyce; Bruno Bockorny; Donna Neuberg; Kenneth A. Bauer et al.
Source: check_circle
Crossref

Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma

Blood
2019-08-15 | Journal article
DOI: 10.1182/blood.2019001272
Contributors: Jeremy S. Abramson; Jon E. Arnason; Ann S. LaCasce; Robert Redd; Jeffrey A. Barnes; Lubomir Sokol; Robin Joyce; David Avigan; Donna Neuberg; Ronald W. Takvorian et al.
Source: check_circle
Crossref

Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia

Blood Advances
2019-04-09 | Journal article
DOI: 10.1182/bloodadvances.2018030221
Contributors: Benjamin L. Lampson; Haesook T. Kim; Matthew S. Davids; Jeremy S. Abramson; Arnold S. Freedman; Caron A. Jacobson; Philippe A. Armand; Robin M. Joyce; Jon E. Arnason; Laura Z. Rassenti et al.
Source: check_circle
Crossref

Phase I Clinical Trial Evaluating Abatacept in Patients with Steroid-Refractory Chronic Graft Versus Host Disease

Biology of Blood and Marrow Transplantation
2017-03 | Journal article
DOI: 10.1016/j.bbmt.2016.12.329
Part of ISSN: 1083-8791
Contributors: Myrna R. Nahas; Robert J. Soiffer; Edwin P. Alyea; Jon E. Arnason; Robin Joyce; Joseph H. Antin; Vincent T. Ho; Dina Stroopinsky; James D. Levine; Malgorzata McMasters et al.
Source: Self-asserted source
Robin Joyce via Crossref Metadata Search

Clinical Trial Evaluating DC/AML Fusion Cell Vaccination in AML Patients Who Achieve a Chemotherapy-Induced Remission

Biology of Blood and Marrow Transplantation
2014-02 | Journal article
DOI: 10.1016/j.bbmt.2013.12.050
Part of ISSN: 1083-8791
Contributors: Jacalyn Rosenblatt; Richard M. Stone; Lynne Uhl; Donna Neuberg; Baldev Vasir; Poorvi Somaiya; Robin Joyce; James D. Levine; Vassiliki A. Boussiotis; Jeffrey Zwicker et al.
Source: Self-asserted source
Robin Joyce via Crossref Metadata Search

Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
2013-02 | Journal article
DOI: 10.1016/j.bbmt.2012.11.021
Part of ISSN: 1083-8791
Contributors: Jacalyn Rosenblatt; Irit Avivi; David Vasir; Lynne Uhl; Tami Katz; Poorvi Somaiya; Heidi Mills; Robin Joyce; James D. Levine; Vassiliki A. Boussiotis et al.
Source: Self-asserted source
Robin Joyce via Crossref Metadata Search

Addition of Clofarabine to TLI/ATG Conditioning: Impact on Immune Reconstitution and Clinical Outcomes

Biology of Blood and Marrow Transplantation
2012-02 | Journal article
DOI: 10.1016/j.bbmt.2011.12.029
Part of ISSN: 1083-8791
Contributors: B. Glotzbecker; H. Mills; J. Rosenblatt; R. Joyce; J. Levine; D. Tzachanis; M. Stevenson; E. Attar; K. Ballen; Y.-B. Chen et al.
Source: Self-asserted source
Robin Joyce via Crossref Metadata Search

Clinical Trial Evaluating DC/AML Fusion Cell Vaccination Alone and in Conjunction with PD-1 Blockade in AML Patients Who Achieve a Chemotherapy-Induced Remission

Biology of Blood and Marrow Transplantation
2012-02 | Journal article
DOI: 10.1016/j.bbmt.2011.12.504
Part of ISSN: 1083-8791
Contributors: J. Rosenblatt; R. Stone; I. Avivi; L. Uhl; D. Neuberg; R.M. Joyce; D. Tzachanis; J.D. Levine; V. Boussiotis; J. Zwicker et al.
Source: Self-asserted source
Robin Joyce via Crossref Metadata Search

Muc1 Inhibition Reverses the Poor Immunogenicity of Leukemia Stem Cells Rendering Them Susceptible to Immunotherapy

Biology of Blood and Marrow Transplantation
2012-02 | Journal article
DOI: 10.1016/j.bbmt.2011.12.295
Part of ISSN: 1083-8791
Contributors: J. Rosenblatt; D. Stroopinsky; H. Mills; K. Luptakova; B. Vasir; R.M. Joyce; J.D. Levine; D. Tzachanis; J. Arnason; I. Galinsky et al.
Source: Self-asserted source
Robin Joyce via Crossref Metadata Search

Dendritic Cell Tumor Fusion Vaccination In Conjunction With Autologous Transplantation For Multiple Myeloma

Biology of Blood and Marrow Transplantation
2010-02 | Journal article
DOI: 10.1016/j.bbmt.2009.12.087
Part of ISSN: 1083-8791
Contributors: J. Rosenblatt; I. Avivi; B. Vasir; T. Katz; L. Uhl; Z. Wu; P. Somaiya; H. Mills; R.M. Joyce; J.D. Levine et al.
Source: Self-asserted source
Robin Joyce via Crossref Metadata Search

Immune Reconstitution Following Reduced Intensity Conditioning With CAMPATH-1H Versus Total Lymphoid Irradiation/Anti-Thymocyte Globulin Prior To Allogeneic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
2010-02 | Journal article
DOI: 10.1016/j.bbmt.2009.12.203
Part of ISSN: 1083-8791
Contributors: B. Glotzbecker; H. Mills; J. Rosenblatt; Z. Wu; K. Wellenstein; B. Vasir; R. Joyce; J. Levine; D. Tzachanis; J. Zwicker et al.
Source: Self-asserted source
Robin Joyce via Crossref Metadata Search

Adoptive T Cell Therapy Using Educated T Cells Generated By the Sequential Stimulation With Dc/Tumor Fusion Cells and Anti-CD3/CD28

Biology of Blood and Marrow Transplantation
2009-02 | Journal article
DOI: 10.1016/j.bbmt.2008.12.188
Part of ISSN: 1083-8791
Contributors: J. Rosenblatt; B. Vasir; Z. Wu; C. Zarwan; R. Stone; A. Bissonnette; T. Friedman; K. Stevenson; D. Neuberg; H. Mills et al.
Source: Self-asserted source
Robin Joyce via Crossref Metadata Search

Fusion Cell Vaccination In Conjunction With Stem Cell Transplantation Is Well Tolerated, Induces Anti-Tumor Immunity and Is Associated With Responses In Patients With Multiple Myeloma

Biology of Blood and Marrow Transplantation
2009-02 | Journal article
DOI: 10.1016/j.bbmt.2008.12.202
Part of ISSN: 1083-8791
Contributors: D. Avigan; J. Rosenblatt; B. Vasir; Z. Wu; A. Bissonnette; P. Somaiya; C. MacNamara; L. Uhl; I. Avivi; T. Katz et al.
Source: Self-asserted source
Robin Joyce via Crossref Metadata Search

Immunomodulatory Effects Of Vitamin D: Implications For The Treatment Of Graft Versus Host Disease

Biology of Blood and Marrow Transplantation
2009-02 | Journal article
DOI: 10.1016/j.bbmt.2008.12.403
Part of ISSN: 1083-8791
Contributors: J. Rosenblatt; A. Bissonnette; Z. Wu; B. Vasir; C. Zarwan; W. Keefe; R. Joyce; J.D. Levine; B. Glotzbecker; H. Mills et al.
Source: Self-asserted source
Robin Joyce via Crossref Metadata Search

172: Phase I Study of Vaccination with Dendritic Cell Myeloma Fusions

Biology of Blood and Marrow Transplantation
2008-02 | Journal article
DOI: 10.1016/j.bbmt.2007.12.181
Part of ISSN: 1083-8791
Contributors: D. Avigan; J. Rosenblatt; B. Vasir; Z. Wu; A. Bissonnette; C. MacNamara; L. Uhl; C. Lenahan; K. Miller; R. Joyce et al.
Source: Self-asserted source
Robin Joyce via Crossref Metadata Search

56: Vaccination with DC/MM Fusions in Conjunction with Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
2008-02 | Journal article
DOI: 10.1016/j.bbmt.2007.12.064
Part of ISSN: 1083-8791
Contributors: J. Rosenblatt; B. Vasir; Z. Wu; A. Bissonnette; C. MacNamara; L. Uhl; C. Lenahan; K. Miller; R. Joyce; J.D. Levine et al.
Source: Self-asserted source
Robin Joyce via Crossref Metadata Search

74: Targeting MUC1 as a Marker for Myeloid Leukemia Stem Cells by DC/AML Fusions

Biology of Blood and Marrow Transplantation
2008-02 | Journal article
DOI: 10.1016/j.bbmt.2007.12.082
Part of ISSN: 1083-8791
Contributors: J. Rosenblatt; Z. Wu; C. Lenahan; A. Bissonnette; B. Vasir; K. Miller; R. Joyce; J.D. Levine; I. Galinsky; R. Stone et al.
Source: Self-asserted source
Robin Joyce via Crossref Metadata Search

63: Vaccination with dendritic cell myeloma fusions alone or in conjunction with stem cell transplantation for patients with multiple myeloma

Biology of Blood and Marrow Transplantation
2007-02 | Journal article
DOI: 10.1016/j.bbmt.2006.12.066
Part of ISSN: 1083-8791
Contributors: D. Avigan; J. Rosenblatt; B. Vasir; Z. Wu; A. Bisonette; C. Macnamarra; L. Uhl; C. Lenahan; K. Miller; R. Joyce et al.
Source: Self-asserted source
Robin Joyce via Crossref Metadata Search

Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation

Biology of Blood and Marrow Transplantation
2005-03 | Journal article
DOI: 10.1016/j.bbmt.2004.12.330
Part of ISSN: 1083-8791
Contributors: Joseph H. Antin; Eva C. Guinan; David Avigan; Robert J. Soiffer; Robin M. Joyce; Victoria J. Martin; Deborah C. Molrine
Source: Self-asserted source
Robin Joyce via Crossref Metadata Search

The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: An analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program

Biology of Blood and Marrow Transplantation
2002-04 | Journal article
DOI: 10.1053/bbmt.2002.v8.pm12017145
Part of ISSN: 1083-8791
Contributors: A.D Elias; J Ibrahim; P Richardson; D Avigan; R Joyce; E Reich; M McCauley; C Wheeler; E Frei
Source: Self-asserted source
Robin Joyce via Crossref Metadata Search
How many people are using ORCID?